151 related articles for article (PubMed ID: 20667109)
1. Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.
Huang L; Chen C
AIDS Res Ther; 2010 Jul; 7():27. PubMed ID: 20667109
[TBL] [Abstract][Full Text] [Related]
2. Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.
Tien C; Huang L; Watanabe SM; Speidel JT; Carter CA; Chen C
PLoS One; 2018; 13(1):e0191372. PubMed ID: 29338056
[TBL] [Abstract][Full Text] [Related]
3. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C
PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662
[TBL] [Abstract][Full Text] [Related]
4. Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions.
Huang L; Li Y; Chen C
Retrovirology; 2011 Oct; 8():79. PubMed ID: 21985091
[TBL] [Abstract][Full Text] [Related]
5. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
Agniswamy J; Sayer JM; Weber IT; Louis JM
Biochemistry; 2012 Feb; 51(5):1041-50. PubMed ID: 22242794
[TBL] [Abstract][Full Text] [Related]
6. Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.
Louis JM; Deshmukh L; Sayer JM; Aniana A; Clore GM
Biochemistry; 2015 Sep; 54(35):5414-24. PubMed ID: 26266692
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.
Huang L; Sayer JM; Swinford M; Louis JM; Chen C
J Virol; 2009 Aug; 83(15):7789-93. PubMed ID: 19457992
[TBL] [Abstract][Full Text] [Related]
8. Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.
Davis DA; Soule EE; Davidoff KS; Daniels SI; Naiman NE; Yarchoan R
Antimicrob Agents Chemother; 2012 Jul; 56(7):3620-8. PubMed ID: 22508308
[TBL] [Abstract][Full Text] [Related]
9. Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment.
Huang L; Li L; Tien C; LaBarbera DV; Chen C
Sci Rep; 2019 Jan; 9(1):301. PubMed ID: 30670786
[TBL] [Abstract][Full Text] [Related]
10. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing.
Zybarth G; Carter C
J Virol; 1995 Jun; 69(6):3878-84. PubMed ID: 7745738
[TBL] [Abstract][Full Text] [Related]
11. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
[TBL] [Abstract][Full Text] [Related]
12. Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.
Tang C; Louis JM; Aniana A; Suh JY; Clore GM
Nature; 2008 Oct; 455(7213):693-6. PubMed ID: 18833280
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors.
Louis JM; Aniana A; Weber IT; Sayer JM
Proc Natl Acad Sci U S A; 2011 May; 108(22):9072-7. PubMed ID: 21576495
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1.
Co E; Koelsch G; Lin Y; Ido E; Hartsuck JA; Tang J
Biochemistry; 1994 Feb; 33(5):1248-54. PubMed ID: 8110758
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Wu X; Liu H; Xiao H; Conway JA; Kappes JC
J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
[TBL] [Abstract][Full Text] [Related]
16. Autoprocessing: an essential step for the activation of HIV-1 protease.
Wan M; Takagi M; Loh BN; Xu XZ; Imanaka T
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):569-73. PubMed ID: 8687402
[TBL] [Abstract][Full Text] [Related]
17. Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.
Huang L; Hall A; Chen C
Retrovirology; 2010 Mar; 7():24. PubMed ID: 20331855
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.
Debouck C; Gorniak JG; Strickler JE; Meek TD; Metcalf BW; Rosenberg M
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8903-6. PubMed ID: 3321060
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
Zybarth G; Kräusslich HG; Partin K; Carter C
J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734
[TBL] [Abstract][Full Text] [Related]
20. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing.
Chiu HC; Wang FD; Chen YA; Wang CT
J Gen Virol; 2006 Jul; 87(Pt 7):2041-2046. PubMed ID: 16760407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
